Adverse Events Following COVID-19 Vaccination in Malaysia: A Cross-Sectional Study
DOI:
https://doi.org/10.31674/mjmr.2026.v010i01.007Abstract
Background: Vaccination remains the most effective strategy for controlling the COVID-19 pandemic. However, the COVID-19 vaccinations have been linked to a number of side effects. This study aimed to assess the frequency of vaccine-related adverse events among individuals in Malaysia. Methods: A cross-sectional, online questionnaire-based survey was conducted among vaccinated individuals in Malaysia from March to November 2024. Participants were recruited using a snowball sampling method, in which the initial respondents were invited through social media platforms and institutional networks and were encouraged to share the survey link with other eligible individuals. A 17-item self-administered questionnaire was designed, validated, and subsequently distributed through online platforms. The inclusion criteria encompassed Malaysian residents aged 18 years and above who had received at least one dose of a COVID-19 vaccine, were able to read and understand English or Malay, and provided informed consent prior to participation. Respondents were excluded if they were below 18 years of age, unvaccinated, or submitted incomplete or inconsistent responses. Result: Of 408 respondents, 288 (70.6%) reported experiencing side effects. Females (66.3%) and individuals aged 45–54 years (26.4%) were more likely to report adverse events. Fever was the most common side effect, with the highest proportion observed among Pfizer vaccine recipients (71.4%). The majority of participants (92%) reported only mild to moderate effects, such as fever and localized injection-site pain, which resolved without hospitalization. A substantial proportion (74.2%) of respondents reported prior COVID-19 infection. Conclusion: This study provides important insights into post-COVID-19 vaccination experiences in Malaysia. Most adverse events were mild and self-limiting, with only a small fraction requiring medical attention.
Keywords:
COVID-19 Vaccine, Cross-Sectional Survey, Malaysia, Side Effects, Vaccine SafetyDownloads
References
Ab Rahman, N., Lim, M. T., Lee, F. Y., Lee, S. C., Ramli, A., Saharudin, S. N., ... & SAFECOVAC study group. (2022). Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study. Vaccine, 40(32), 4394-4402. https://doi.org/10.1016/j.vaccine.2022.05.075
Al Khames Aga, Q. A., Alkhaffaf, W. H., Hatem, T. H., Nassir, K. F., Batineh, Y., Dahham, A. T., ... & Traqchi, M. (2021). Safety of COVID‐19 vaccines. Journal of Medical Virology, 93(12), 6588-6594. https://doi.org/10.1002/jmv.27214
Alghamdi, A., Ibrahim, A., Almutairi, R., Joseph, M., Alghamdi, G., & Alhamza, A. (2021). A cross-sectional survey of side effects after COVID-19 vaccination in Saudi Arabia: Male versus female outcomes. Journal of Advanced Pharmacy Education & Research, 11(2), 51-56. https://doi.org/10.51847/bCwca2qGfP
Alhazmi, A., Alamer, E., Daws, D., Hakami, M., Darraj, M., Abdelwahab, S., ... & Algaissi, A. (2021). Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia. Vaccines, 9(6), 674. https://doi.org/10.3390/vaccines9060674
Centers for Disease Control and Prevention (CDC). (2025). Coronavirus Disease 2019 (COVID 19) vaccine safety. U.S. Department of Health & Human Services. https://www.cdc.gov/vaccine-safety/vaccines/covid-19.html
De Bruin, Y. B., Lequarre, A. S., McCourt, J., Clevestig, P., Pigazzani, F., Jeddi, M. Z., ... & Goulart, M. (2020). Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic. Safety Science, 128, 104773. https://doi.org/10.1016/j.ssci.2020.104773
El-Shitany, N. A., Harakeh, S., Badr-Eldin, S. M., Bagher, A. M., Eid, B., Almukadi, H., ... & El-Hamamsy, M. (2021). Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. International Journal of General Medicine, 1389-1401. https://doi.org/10.1016/j.ssci.2020.104773
Feng, W., Zong, W., Wang, F., & Ju, S. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review. Molecular Cancer, 19(1), 100. https://doi.org/10.1186/s12943-020-01218-1
Fleisher, T. A., Shearer, W. T., Frew, A. J., Schroeder Jr, H. W., & Weyand, C. M. (2013). Clinical immunology, principles and practice (Expert Consult-Online and Print), 4: Clinical immunology. Elsevier Health Sciences.
Hamdan, N. E. A., Fahrni, M. L., & Lazzarino, A. I. (2022). COVID-19 vaccination prioritization strategies in Malaysia: a retrospective analysis of early evidence. Vaccines, 11(1), 48. https://doi.org/10.3390/vaccines11010048
He, Q., Mao, Q., Zhang, J., Bian, L., Gao, F., Wang, J., ... & Liang, Z. (2021). COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations. Frontiers in Immunology, 12, 669339. https://doi.org/10.3389/fimmu.2021.669339
Karuppannan, M., Ming, L. C., Abd Wahab, M. S., Mohd Noordin, Z., Yee, S., & Hermansyah, A. (2024). Self-reported side effects of COVID-19 vaccines among the public. Journal of Pharmaceutical Policy and Practice, 17(1), 2308617. https://doi.org/10.1080/20523211.2024.2308617
Kiely, M., Tadount, F., Lo, E., Sadarangani, M., Wei, S. Q., Rafferty, E., ... & MacDonald, S. E. (2023). Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. Journal of Epidemiol Community Health, 77(12), 791-801. https://doi.org/10.1136/jech-2023-220781
Klein, S. L., & Flanagan, K. L. (2016). Sex differences in immune responses. Nature Reviews Immunology, 16(10), 626-638. https://doi.org/10.1038/nri.2016.90
Klein, S. L., Jedlicka, A., & Pekosz, A. (2010). The Xs and Y of immune responses to viral vaccines. The Lancet infectious diseases, 10(5), 338-349. https://www.thelancet.com/journals/laninf/article/PIIS1473309910700499/abstract
Klugar, M., Riad, A., Mekhemar, M., Conrad, J., Buchbender, M., Howaldt, H. P., & Attia, S. (2021). Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers. Biology, 10(8), 752. https://doi.org/10.3390/biology10080752
Lee, K. W., Yap, S. F., Ong, H. T., Oo, M., & Swe, K. M. M. (2023). COVID-19 vaccine booster hesitancy in Malaysia: a web-based cross-sectional study. Vaccines, 11(3), 638. https://doi.org/10.3390/vaccines11030638
Mehta, O. P., Bhandari, P., Raut, A., Kacimi, S. E. O., & Huy, N. T. (2021). Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Frontiers in Public Health, 8, 582932. https://doi.org/10.3389/fpubh.2020.582932
Ministry of Health Malaysia. (2025). COVID 19 Vaccination: Vaccination Progress by State. Ministry of Health Malaysia. https://data.moh.gov.my/dashboard/covid vaccination
Ministry of Health Malaysia. (n.d.). Vaccinations — COVIDNOW. COVIDNOW Malaysia. Retrieved December 12, 2025, from https://covidnow.moh.gov.my/vaccinations
Ng, J. W. J., Vaithilingam, S., Nair, M., Hwang, L. A., & Musa, K. I. (2022). Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework. PLoS One, 17(5), e0268926. https://doi.org/10.1371/journal.pone.0268926
Omeish, H., Najadat, A., Al-Azzam, S., Tarabin, N., Abu Hameed, A., Al-Gallab, N., ... & Aldeyab, M. A. (2022). Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study. Human Vaccines & Immunotherapeutics, 18(1), 1981086. https://doi.org/10.1080/21645515.2021.1981086
Onyeaka, H., Anumudu, C. K., Al-Sharify, Z. T., Egele-Godswill, E., & Mbaegbu, P. (2021). COVID-19 pandemic: A review of the global lockdown and its far-reaching effects. Science Progress, 104(2), 00368504211019854. https://doi.org/10.1177/003685042110198
Ossato, A., Tessari, R., Trabucchi, C., Zuppini, T., Realdon, N., & Marchesini, F. (2023). Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021. European Journal of Hospital Pharmacy, 30(4), e15-e15. https://doi.org/10.1136/ejhpharm-2021-002933
Peng, X. L., Cheng, J. S. Y., Gong, H. L., Yuan, M. D., Zhao, X. H., Li, Z., & Wei, D. X. (2021). Advances in the design and development of SARS-CoV-2 vaccines. Military Medical Research, 8(1), 67. https://doi.org/10.1186/s40779-021-00360-1
Riad, A., Pokorná, A., Attia, S., Klugarová, J., Koščík, M., & Klugar, M. (2021). Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. Journal of Clinical Medicine, 10(7), 1428. https://doi.org/10.3390/jcm10071428
Saeed, B. Q., Al-Shahrabi, R., Alhaj, S. S., Alkokhardi, Z. M., & Adrees, A. O. (2021). Side effects and perceptions following Sinopharm COVID-19 vaccination. International Journal of Infectious Diseases, 111, 219-226. https://doi.org/10.1016/j.ijid.2021.08.013
Suah, J. L., Tok, P. S. K., Ong, S. M., Husin, M., Tng, B. H., Sivasampu, S., ... & Peariasamy, K. M. (2021). PICK-ing Malaysia’s epidemic apart: effectiveness of a diverse COVID-19 vaccine portfolio. Vaccines, 9(12), 1381. https://doi.org/10.3390/vaccines9121381
Syed Alwi, S. A. R., Rafidah, E., Zurraini, A., Juslina, O., Brohi, I. B., & Lukas, S. (2021). A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC public health, 21(1), 1129. https://doi.org/10.1186/s12889-021-11071-6
Yaamika, H., Muralidas, D., & Elumalai, K. (2023). Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases. Journal of Taibah University Medical Sciences, 18(6), 1646-1661. https://doi.org/10.1016/j.jtumed.2023.08.004
Zaim, S., Chong, J. H., Sankaranarayanan, V., & Harky, A. (2020). COVID-19 and multiorgan response. Current Problems in Cardiology, 45(8), 100618. https://doi.org/10.1016/j.cpcardiol.2020.100618
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Malaysian Journal of Medical Research (MJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
